Company Analysis

Bio Green Med Solution, Inc. (BGMS)

Nasdaq: BGMS · Pharmaceutical Preparations · Berkeley Heights, NJ · filing with the SEC since 2000
Grade4.3
◀ Past 4.1● Present 3.3▶ Future 5.2
2 est.

Filings

425 filings since 2017 beside 136 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 43 days after the quarter ended. The proxy statement was last filed Apr 27, 2026.

Filings a yearinsider forms included
37564432515816934
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Listing warning from its exchange (8-K item 3.01): 10 times in the last 36 months, the newest Nov 4, 2026.Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Sep 25, 2025.Auditor change (8-K item 4.01): 3 times in the last 36 months, the newest Aug 28, 2025.Warning not to rely on past financial statements (8-K item 4.02): 1 time in the last 36 months, the newest Nov 15, 2023.SEC letters: 16 in the last 36 months, the newest Aug 22, 2025.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-Q, filed Nov 15, 2023.
Insider forms 136

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 12, 2026 EFFECT Registration effective
Nov 12, 2026 424B3 Shelf offering
Nov 12, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 12, 2026 10-Q Quarterly report Sep 30, 2026
Nov 4, 2026 8-K items 3.01, 9.01 Listing warning from its exchange · Current report Oct 29, 2026
Oct 23, 2026 S-3 Shelf registration
Oct 16, 2026 8-K item 8.01 Other event · Current report
Oct 9, 2026 424B3 Shelf offering
Oct 8, 2026 EFFECT Registration effective
Sep 11, 2026 S-4/A Merger or exchange registration, amended
Aug 21, 2026 S-4/A Merger or exchange registration, amended
Aug 14, 2026 10-Q Quarterly report Jun 30, 2026
Aug 14, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report Aug 12, 2026
Aug 12, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 12, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 24, 2026 S-4/A Merger or exchange registration, amended
Jul 1, 2026 8-K item 8.01 Other event · Current report
Jun 22, 2026 8-K items 5.07, 9.01 Shareholder vote · Current report Jun 18, 2026
Jun 16, 2026 S-4 Merger or exchange registration
Jun 10, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report
Jun 4, 2026 425 Merger communication
Jun 4, 2026 8-K items 1.01, 7.01, 9.01 Major agreement signed; Investor disclosure (Regulation FD) · Current report
May 15, 2026 10-Q Quarterly report Mar 31, 2026
May 14, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
May 12, 2026 SCHEDULE 13G/A Large holder update, amended
May 1, 2026 DEFR14A Revised proxy statement
Apr 27, 2026 DEF 14A Proxy statement
Apr 13, 2026 8-K item 8.01 Other event · Current report
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 30, 2026 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Mar 13, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 13, 2026 SCHEDULE 13G/A Large holder update, amended
Mar 13, 2026 8-K item 3.01 Listing warning from its exchange · Current report Mar 12, 2026
Jan 12, 2026 8-K item 8.01 Other event · Current report
Nov 28, 2025 S-8 Employee stock plan registration
Nov 26, 2025 10-K/A Annual report, amended Dec 31, 2024
Nov 13, 2025 SCHEDULE 13D/A Activist holder update, amended
Nov 13, 2025 10-Q Quarterly report Sep 30, 2025
Nov 13, 2025 8-K items 2.02, 7.01, 9.01 Results released; Investor disclosure (Regulation FD) · Current report
Nov 6, 2025 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report Nov 5, 2025
40 of 425 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton BGMS · research, not advice